Molson Coors gains exclusive rights for Fever-Tree mixers in the U.S. Molson Coors acquires 8.5% stake in Fever-Tree as part of partnership. Get Pro-Level Earnings Insights Before the Market Moves ...
Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of $74.00. Christopher Carey’s rating is based on Molson ...
CHICAGO, January 30, 2025--(BUSINESS WIRE)--Molson Coors Beverage Company ("Molson Coors" or "the company") (NYSE: TAP, TAP.A) is expanding its U.S. non-alc portfolio through a new strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback